US-based pharmaceutical company AbbVie has reported the final analysis from the Phase III MIRASOL trial, which assessed its ...

AbbVie has pointed to a very strong launch trajectory for Elahere, with sales rocketing to $480 million last year, almost ...

Immunotherapy, or antibody treatment that activates the patient's own immune system against cancer, is increasingly being ...

Immunotherapy, or antibody treatment that activates the patient’s own immune system against cancer, is increasingly being ...

These conditions hamper the quality of life with their debilitating symptoms—painful periods, heavy and inconsistent bleeding ...

Two months after the last chemotherapy, Bianca Balti resumes her battle against cancer. Fresh from participating in the Milan ...

New research reveals a gap in menopause support for breast cancer survivors and a lack of involvement in decision-making ...

Love Island's Arabella Chi has described her pregnancy as 'extra special' due to her ongoing battle with an incurable disease ...

Pharmaceuticals announced updated clinical data from Part 1b of the ongoing DENALI clinical trial of azenosertib in patients ...

AbbVie (ABBV) announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the efficacy and safety of ...